Enbridge Inc
ENB
Choice Properties Real Estate Investment Trust
CHP.UN
Brookfield Renewable Partners LP
BEP.UN
The Toronto-Dominion Bank
TD
TC Energy Corp
TRP
CA Stock MarketDetailed Quotes
IPA ImmunoPrecise Antibodies Ltd
- 0.000
- 0.0000.00%
15min DelayMarket Closed Dec 20 09:30 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.00052wk High0.00%Turnover Ratio24.94MShares0.00052wk Low-1.06EPS TTM0Float Cap0.000Historical High0.00P/E (Static)24.94MShs Float0.000Historical Low-0.85EPS LYR0.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
ImmunoPrecise Antibodies Ltd Key Stats
Quarterly+Annual
YOY
| (Q1)Jul 31, 2022 | (FY)Apr 30, 2022 | (Q4)Apr 30, 2022 | (Q3)Jan 31, 2022 | (Q2)Oct 31, 2021 | (Q1)Jul 31, 2021 | (FY)Apr 30, 2021 | (Q4)Apr 30, 2021 | (Q3)Jan 31, 2021 | (Q2)Oct 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.20%4.69M | 8.11%19.36M | 7.42%5.24M | 6.64%4.82M | -0.69%4.72M | 21.86%4.59M | 27.41%17.91M | 17.66%4.88M | 11.91%4.52M | 50.36%4.76M |
| Operating revenue | 2.20%4.69M | 8.11%19.36M | 7.42%5.24M | 6.64%4.82M | -0.69%4.72M | 21.86%4.59M | 27.41%17.91M | 17.66%4.88M | 11.91%4.52M | 50.36%4.76M |
| Cost of revenue | 6.15%2.21M | 31.49%8.38M | -8.43%1.92M | 133.89%2.23M | 9.21%2.15M | 53.65%2.08M | 5.81%6.37M | -4.60%2.1M | -47.37%953K | 192.41%1.97M |
| Gross profit | -1.08%2.48M | -4.81%10.98M | 19.41%3.32M | -27.40%2.59M | -7.67%2.58M | 3.98%2.51M | 43.61%11.54M | 42.86%2.78M | 60.19%3.56M | 12.01%2.79M |
| Operating expense | 107.86%12.22M | 72.79%27.15M | 42.42%7.47M | 47.08%6.64M | 107.57%7.16M | 134.96%5.88M | 32.50%15.71M | 68.67%5.25M | 86.52%4.52M | -0.97%3.45M |
| Selling and administrative expenses | 29.52%5.24M | 32.77%17.71M | 29.55%5.87M | 7.43%4.17M | 24.58%3.63M | 100.55%4.05M | 60.17%13.34M | 57.74%4.53M | 240.88%3.88M | 30.51%2.91M |
| -Selling and marketing expense | 90.80%311K | 7.09%740K | -18.82%151K | 5.56%228K | -22.66%198K | 393.94%163K | 82.80%691K | 22.58%186K | 348.91%216K | 320.02%256K |
| -General and administrative expense | 26.94%4.93M | 34.17%16.97M | 31.62%5.72M | 7.54%3.94M | 29.13%3.43M | 95.67%3.88M | 59.09%12.65M | 59.70%4.35M | 236.11%3.66M | 22.38%2.66M |
| Research and development costs | 416.35%5.78M | 239.06%6.69M | 47.08%906K | --1.82M | 171.50%2.85M | 262.14%1.12M | 342.60%1.97M | 378.37%616K | --0 | 135.29%1.05M |
| Depreciation amortization depletion | 85.97%1.25M | -6.21%2.57M | 1.14%619K | -12.72%638K | -10.61%640K | -1.18%670K | 6.37%2.74M | 23.50%612K | -6.65%731K | -4.09%716K |
| -Depreciation and amortization | 85.97%1.25M | -6.21%2.57M | 1.14%619K | -12.72%638K | -10.61%640K | -1.18%670K | 6.37%2.74M | 23.50%612K | -6.65%731K | -4.09%716K |
| Other operating expenses | -182.98%-39K | 107.83%183K | 115.23%78K | 119.35%18K | 103.25%40K | 109.38%47K | -555.36%-2.34M | -1,327.93%-512K | -120.84%-93K | -2,242.11%-1.23M |
| Operating profit | -188.74%-9.75M | -287.21%-16.17M | -68.30%-4.16M | -325.16%-4.06M | -595.30%-4.58M | -3,529.03%-3.38M | -9.15%-4.18M | -111.68%-2.47M | -383.00%-954K | 33.56%-659K |
| Net non-operating interest income (expenses) | 49.49%-50K | 75.90%-140K | 102.87%13K | 127.39%43K | -135.93%-97K | 58.75%-99K | 58.05%-581K | -137.69%-453K | 37.08%-157K | 194.59%270K |
| Non-operating interest income | ---- | -1.06%279K | 139.64%109K | 1,233.33%160K | -98.83%6K | --4K | 442.31%282K | -11,033.60%-275K | --12K | 1,117.52%515K |
| Non-operating interest expense | -51.46%50K | -51.45%419K | -46.07%96K | -30.77%117K | -57.96%103K | -57.08%103K | -39.94%863K | -5.38%178K | -32.27%169K | -25.25%245K |
| Other net income (expenses) | -97.45%11K | 137.32%462K | 79.34%-225K | 520.21%395K | -566.67%-140K | 1,334.29%432K | -1,409.76%-1.24M | -756.56%-1.09M | -135.47%-94K | 24.78%-21K |
| Gain on sale of security | -96.74%14K | 150.81%627K | 80.23%-210K | 692.71%569K | -519.23%-161K | 2,245.00%429K | -1,682.05%-1.23M | -10,181.73%-1.06M | -231.29%-96K | -700.32%-26K |
| Special income (charges) | -200.00%-3K | -4,025.00%-165K | 44.44%-15K | -8,800.00%-174K | 320.00%21K | 120.00%3K | 97.50%-4K | 76.89%-27K | 118.28%2K | 115.50%5K |
| -Less:Impairment of capital assets | ---- | --167K | --0 | --167K | ---- | ---- | --0 | --0 | --0 | ---- |
| -Less:Write off | 200.00%3K | -150.00%-2K | -44.44%15K | 450.00%7K | -320.00%-21K | 81.25%-3K | -91.67%4K | 461.56%27K | -118.28%-2K | -115.50%-5K |
| Income before tax | -221.63%-9.78M | -164.35%-15.85M | -8.90%-4.37M | -200.25%-3.62M | -1,075.37%-4.82M | -726.63%-3.04M | -13.26%-6M | -170.24%-4.01M | -147.46%-1.21M | 68.59%-410K |
| Income tax | -314.36%-403K | -35.99%861K | -73.07%275K | 133.71%208K | 251.85%190K | 3.87%188K | 488.73%1.35M | 289.36%1.02M | -35.92%89K | -7.44%54K |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -190.43%-9.38M | -127.64%-16.71M | 7.73%-4.64M | -195.67%-3.83M | -979.53%-5.01M | -488.34%-3.23M | -48.37%-7.34M | -432.36%-5.03M | -106.76%-1.29M | 65.97%-464K |
| Net income continuous operations | -190.43%-9.38M | -127.64%-16.71M | 7.73%-4.64M | -195.67%-3.83M | -979.53%-5.01M | -488.34%-3.23M | -48.37%-7.34M | -432.36%-5.03M | -106.76%-1.29M | 65.97%-464K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -190.43%-9.38M | -127.64%-16.71M | 7.73%-4.64M | -195.67%-3.83M | -979.53%-5.01M | -488.34%-3.23M | -48.37%-7.34M | -432.36%-5.03M | -106.76%-1.29M | 65.97%-464K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -190.43%-9.38M | -127.64%-16.71M | 7.73%-4.64M | -195.67%-3.83M | -979.53%-5.01M | -488.34%-3.23M | -48.37%-7.34M | -432.36%-5.03M | -106.76%-1.29M | 65.97%-464K |
| Diluted earnings per share | -123.53%-0.38 | -88.89%-0.85 | 23.33%-0.23 | -150.00%-0.2 | -766.67%-0.26 | -325.00%-0.17 | -25.00%-0.45 | -328.57%-0.3 | -60.00%-0.08 | 70.00%-0.03 |
| Basic earnings per share | -123.53%-0.38 | -88.89%-0.85 | 23.33%-0.23 | -150.00%-0.2 | -766.67%-0.26 | -325.00%-0.17 | -25.00%-0.45 | -328.57%-0.3 | -60.00%-0.08 | 70.00%-0.03 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Trending CA Stocks
Dividend Kings of Canada Dividend Kings of Canada
Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.